Loading...
Please wait, while we are loading the content...
Similar Documents
The MHC class Ib protein ULBP1 is a nonredundant determinant of leukemia/lymphoma susceptibility to γδ T-cell cytotoxicity
| Content Provider | Scilit |
|---|---|
| Author | Lança, Telma Correia, Daniel V. Moita, Catarina F. Raquel, Helena Neves-Costa, Ana Ferreira, Cristina Ramalho, José S. Barata, João T. Moita, Luís F. Gomes, Anita Q. Silva-Santos, Bruno |
| Copyright Year | 2010 |
| Description | On the path to successful immunotherapy of hematopoietic tumors, γδ T cells offer great promise because of their human leukocyte antigen (HLA)–unrestricted targeting of a wide variety of leukemias/lymphomas. However, the molecular mechanisms underlying lymphoma recognition by γδ T cells remain unclear. Here we show that the expression levels of UL16-binding protein 1 (ULBP1) determine lymphoma susceptibility to γδ T cell–mediated cytolysis. Consistent with this, blockade of NKG2D, the receptor for ULBP1 expressed on all Vγ9+ T cells, significantly inhibits lymphoma cell killing. Specific loss-of-function studies demonstrate that the role of ULBP1 is nonredundant, highlighting a thus far unique physiologic relevance for tumor recognition by γδ T cells. Importantly, we observed a very wide spectrum of ULBP1 expression levels in primary biopsies obtained from lymphoma and leukemia patients. We suggest this will impact on the responsiveness to γδ T cell–based immunotherapy, and therefore propose ULBP1 to be used as a leukemia/lymphoma biomarker in upcoming clinical trials. |
| Related Links | http://www.bloodjournal.org/content/115/12/2407.full.pdf |
| Ending Page | 2411 |
| Page Count | 5 |
| Starting Page | 2407 |
| DOI | 10.1182/blood-2009-08-237123 |
| Journal | Blood |
| Issue Number | 12 |
| Volume Number | 115 |
| Language | English |
| Publisher | American Society of Hematology |
| Publisher Date | 2010-03-25 |
| Access Restriction | Open |
| Subject Keyword | Research and Experimental Medicine Protein Antigen Ulbp1 Hematopoietic Γδ T Cells Immunotherapy Function Lymphoma Nonredundant Journal: Blood (Vol- 121, Issue- 12) |
| Content Type | Text |
| Resource Type | Article |